Conference Call with Vijaya Diagnostic Centre Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Vijaya Diagnostic Centre announced Q2FY25 results Revenue from Operations: Rs 1,829.5 million compared to Rs 1,388.6 million during Q2FY24, change 31.8%. EBITDA: Rs 759.8 million compared to Rs 573.7 million during Q2FY24, change 32.5%. EBITDA Margin: 41.5% for Q2FY25. PAT: Rs 419.4 million compared to Rs 333.2 million during Q2FY24, change 26.9%. PAT margin: 22.9% for Q2FY25. Suprita Reddy, MD & CEO said: “I’m excited to announce another key milestone in our growth journey. We have delivered a robust quarter, achieving an impressive 31.8% YoY revenue growth, of which 23.0% was organic. This strong performance was driven primarily by volume, with contributions coming from both our existing and newly launched centres. I’m also delighted to share that we successfully launched operations at our Hub center in Ongole this August, and the response in the first two months has been very promising. In addition, we are excited to begin operations at our new state-of-the-art facility in Nizamabad tomorrow. This center features cuttingedge technologies, including a 3T MRI, CT scan, an automated lab, and a range of basic radiology modalities. We’ve also upgraded our spoke centre in Gurgaon, transforming it into a fully equipped hub with the addition of MRI and CT machines. This enhancement enables us to provide a complete range of services, from basic blood tests to advanced imaging, all conveniently available under one roof at our Gurgaon centre.” Result PDF
Conference Call with Vijaya Diagnostic Centre Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Vijaya Diagnostic Centre announced Q1FY25 results: Revenue from Operations: Rs 1,562.2 million, showing a 29.1% increase YoY from Rs 1,210.5 million in Q1FY24 and a 0.7% increase QoQ from Rs 1,552.1 million in Q4FY24. Revenue from Operations (excluding PH): Rs 1,448.1 million, a 19.6% YoY increase from Rs 1,210.5 million in Q1FY24 and a 1.0% QoQ increase from Rs 1,434.3 million in Q4FY24. EBITDA: Rs 612.4 million, representing a 27.3% YoY increase from Rs 481.2 million in Q1FY24 but a 3.0% decrease QoQ from Rs 631.1 million in Q4FY24. EBITDA Margin: 39.2%, which is a decrease of 60 basis points YoY from 39.8% in Q1FY24 and a decrease of 150 basis points QoQ from 40.7% in Q4FY24. Profit After Tax (PAT): Rs 313.5 million, reflecting a 19.6% YoY increase from Rs 262.0 million in Q1FY24 but a 6.3% decrease QoQ from Rs 334.5 million in Q4FY24. Commenting on the performance Suprita Reddy, MD & CEO said, “I'm happy to announce another strong quarter, highlighted by a remarkable YoY revenue growth of 29.1%, with an impressive 19.6% achieved organically. This growth was primarily driven by increased footfall and test volume, with our wellness holding strong at 13.4%. I am also happy to share that, our hub center at VIP Road, Kolkata has successfully completed its first year of operations, reaching breakeven within just three quarters. This is a significant milestone in our growth journey, and we are excited about the opportunities the Kolkata market offers. Looking ahead, I am pleased to announce the commencement of operations at our new 10,000-squarefoot, state-of-the-art hub facility in Ongole on August 8th. This facility, equipped with advanced radiology equipment such as a 3T MRI and a 160-slice cardiac CT, will offer a comprehensive range of integrated diagnostic services to our customers across the Palanadu region.” Result PDF